| All patients | Outcome | Indication for ICU | ||||||
---|---|---|---|---|---|---|---|---|---|
Survivor | Non-survivor | Sign | OHCA | IHCA | Card shock | Pulm edema | Sign | ||
Total no of patients (%) | 101 (100) | 67 (66.3) | 34 (33.7) | Â | 37 (36.6) | 32 (31.7) | 23 (22.8) | 9 (8.9) | Â |
Gender Male, no (%) | 70 (69.3) | 48 (47.5) | 22 (21.8) | 0.500 | 29 (28.7) | 20 (19.8) | 15 (14.9) | 6 (5.9) | 0.505 |
Age, years | 65.3 (12.8) | 63.8 (11.5) | 68.3 (14.8) | 0.047 | 60.2 (12.8) | 66.8 (12.6) | 71.2 (10.7) | 66.0 (11.8) | 0.009 |
Cardiovascular risk factors | |||||||||
 Smoking, no (%) | 28 (27.7) | 19 (18.8) | 9 (8.91) | 1.000 | 11 (10.9) | 11 (10.9) | 3 (3.0) | 3 (3.0) | 0.335 |
 Diabetes mellitus, no (%) | 21 (20.8) | 10 (9.9) | 11(10.9) | 0.067 | 4 (4.0) | 7 (6.9) | 8 (7.9) | 2 (2.0) | 0.171 |
 Dyslipidaemia, no (%) | 30 (29.7) | 22 (21.8) | 8 (7.9) | 0.367 | 8 (7.9) | 10 (9.9) | 9 (8.9) | 3 (3.0) | 0.526 |
 Hypertension, no (%) | 58 (57.4) | 40 (39.6) | 18 (17.8) | 0.531 | 18 (17.8) | 17 (16.8) | 16 (15.8) | 7 (6.9) | 0.229 |
Past medical history | |||||||||
 Previous MI, no (%) | 20 (19.8) | 15 (14.9) | 5 (5.0) | 0.436 | 3 (3.0) | 4 (4.0) | 8 (7.9) | 5 (5.0) | 0.002 |
 Previous CAD, no (%) | 29 (28.7) | 21 (20.8) | 8 (7.9) | 0.490 | 4 (4.0) | 9 (8.9) | 10 (9.9) | 6 (5.9) | 0.002 |
 Previous CHF, no (%) | 3 (3.0) | 2 (2.0) | 1 (1.0) | 1.000 | 0 (0.0) | 1 (1.0) | 1 (1.0) | 1 (1.0) | 0.340 |
 Renal failure, no (%) | 12 (11.9) | 8 (7.9) | 4 (4.0) | 1.000 | 3 (3.0) | 2 (2.0) | 5 (5.0) | 2 (2.0) | 0.210 |
 COPD no, no (%) | 11 (10.9) | 9 (8.9) | 2 (2.0) | 0.326 | 3 (3.0) | 6 (5.9) | 0 (0.0) | 2 (2.0) | 0.096 |
Baseline characteristics on admission | |||||||||
 HR (bpm) | 79.7 (15.6) | 78.5 (16.0) | 82.0 (14.5) | 0.297 | 70.6 (15) | 80.4 (12.3) | 87.8 (13.4) | 93.8 (11.7) | < 0.001 |
 Systolic BP (mmHg) | 106.8 (19.5) | 111.8 (17.9) | 96.3 (18.7) | < 0.001 | 106.9 (16.4) | 103.16 (20.7) | 108.9 (21.2) | 114.0 (22.2) | 0.462 |
 MAP (mmHg) | 73.0 (13.0) | 77.7 (10.3) | 63.7 (12.9) | < 0.001 | 72.5 (12.4) | 73.7 (15.3) | 71.4 (9.5) | 77.0 (15.0) | 0.720 |
 PaO2/FiO2 ratio, med (IQR) | 143 (98–233) | 154 (98–271) | 105 (83–173) | 0.036 | 157.9 (105–241) | 165 (83–286) | 105 (83–143) | 128 (75–278) | 0.138 |
 GCS, med (IQR) | 3 (3–15) | 11 (3–15) | 3 (3–3) | < 0.001 | 3 (3–4) | 3 (3–14.5) | 14 (3–15) | 3 (3–15) | 0.071 |
 Serum creatinine (μmol/L), med (IQR) | 116 (87–157) | 102 (84–129) | 156 (115–203) | < 0.001 | 101 (71–126) | 116 (95–155) | 140 (112–191) | 135 (117–144) | 0.012 |
 SOFA score | 8.4 (3.3) | 7.4 (2.9) | 10.4 (3.1) | < 0.001 | 8.6 (2.6) | 8.5 (3.5) | 8.3 (3.4) | 8.0 (5.2) | 0.953 |
Indication for ICU admission | |||||||||
 OHCA, no (%) | 37 (36.6) | 26 (25.7) | 11 (10.9) | 0.663 |  |  |  |  |  |
  Downtime before ROSC (min), (IQR) | 20 (15–30) | 15 (10–20) | 35 (30–40) | < 0.001 |  |  |  |  |  |
 IHCA, no (%) | 32 (31.7) | 19 (18.8) | 13 (12.7) | 0.368 |  |  |  |  |  |
  Downtime before ROSC (min), (IQR) | 10 (5–20) | 9 (5–14) | 15 (5–42) | 0.214 |  |  |  |  |  |
 Cardiogenic shock, no (%) | 23 (22.8) | 14 (13.9) | 9 (8.9) | 0.617 |  |  |  |  |  |
 Acute pulmonary oedema, no (%) | 9 (8.9) | 8 (7.9) | 1 (1.0) | 0.266 |  |  |  |  |  |